Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313482854> ?p ?o ?g. }
- W4313482854 endingPage "172" @default.
- W4313482854 startingPage "172" @default.
- W4313482854 abstract "Importance Keloids and hypertrophic scars (excessive scarring) are relatively understudied disfiguring chronic skin conditions with high treatment resistance. Objective To evaluate established comorbidities of excessive scarring in European individuals, with comparisons across ethnic groups, and to identify novel comorbidities via a phenome-wide association study (PheWAS). Design, Setting, and Participants This multicenter cross-sectional population-based cohort study used UK Biobank (UKB) data and fitted logistic regression models for testing associations between excessive scarring and a variety of outcomes, including previously studied comorbidities and 1518 systematically defined disease categories. Additional modeling was performed within subgroups of participants defined by self-reported ethnicity (as defined in UK Biobank). Of 502 701 UKB participants, analyses were restricted to 230078 individuals with linked primary care records. Exposures Keloid or hypertrophic scar diagnoses. Main Outcomes and Measures Previously studied disease associations (hypertension, uterine leiomyoma, vitamin D deficiency, atopic eczema) and phenotypes defined in the PheWAS Catalog. Results Of the 972 people with excessive scarring, there was a higher proportion of female participants compared with the 229 106 controls (65% vs 55%) and a lower proportion of White ethnicity (86% vs 95%); mean (SD) age of the total cohort was 64 (8) years. Associations were identified with hypertension and atopic eczema in models accounting for age, sex, and ethnicity, and the association with atopic eczema (odds ratio [OR], 1.68; 95% CI, 1.36-2.07; P &lt; .001) remained statistically significant after accounting for additional potential confounders. Fully adjusted analyses within ethnic groups revealed associations with hypertension in Black participants (OR, 2.05; 95% CI, 1.13-3.72; P = .02) and with vitamin D deficiency in Asian participants (OR, 2.24; 95% CI, 1.26-3.97; P = .006). The association with uterine leiomyoma was borderline significant in Black women (OR, 1.93; 95% CI, 1.00-3.71; P = .05), whereas the association with atopic eczema was significant in White participants (OR, 1.68; 95% CI, 1.34-2.12; P &lt; .001) and showed a similar trend in Asian (OR, 2.17; 95% CI, 1.01-4.67; P = .048) and Black participants (OR, 1.89; 95% CI, 0.83-4.28; P = .13). The PheWAS identified 110 significant associations across disease systems; of the nondermatological, musculoskeletal disease and pain symptoms were prominent. Conclusions and Relevance This cross-sectional study validated comorbidities of excessive scarring in UKB with comprehensive coverage of health outcomes. It also documented additional phenome-wide associations that will serve as a reference for future studies to investigate common underlying pathophysiologic mechanisms." @default.
- W4313482854 created "2023-01-06" @default.
- W4313482854 creator A5010784869 @default.
- W4313482854 creator A5015031582 @default.
- W4313482854 creator A5042242906 @default.
- W4313482854 creator A5046355810 @default.
- W4313482854 creator A5049250271 @default.
- W4313482854 creator A5062709888 @default.
- W4313482854 creator A5066408267 @default.
- W4313482854 creator A5083560920 @default.
- W4313482854 date "2023-02-01" @default.
- W4313482854 modified "2023-09-28" @default.
- W4313482854 title "Comorbidities of Keloid and Hypertrophic Scars Among Participants in UK Biobank" @default.
- W4313482854 cites W1527957830 @default.
- W4313482854 cites W1896788661 @default.
- W4313482854 cites W1969476027 @default.
- W4313482854 cites W1975855393 @default.
- W4313482854 cites W1981083893 @default.
- W4313482854 cites W1986814930 @default.
- W4313482854 cites W1989668072 @default.
- W4313482854 cites W2002299533 @default.
- W4313482854 cites W2017619855 @default.
- W4313482854 cites W2022734924 @default.
- W4313482854 cites W2031890048 @default.
- W4313482854 cites W2034042088 @default.
- W4313482854 cites W2045187823 @default.
- W4313482854 cites W2063759812 @default.
- W4313482854 cites W2069283923 @default.
- W4313482854 cites W2082704080 @default.
- W4313482854 cites W2101502016 @default.
- W4313482854 cites W2102215872 @default.
- W4313482854 cites W2115098571 @default.
- W4313482854 cites W2118238130 @default.
- W4313482854 cites W2135310563 @default.
- W4313482854 cites W2144073345 @default.
- W4313482854 cites W2148204120 @default.
- W4313482854 cites W2153059487 @default.
- W4313482854 cites W2159632443 @default.
- W4313482854 cites W2274871785 @default.
- W4313482854 cites W2508927756 @default.
- W4313482854 cites W2524048109 @default.
- W4313482854 cites W2543016513 @default.
- W4313482854 cites W2595206985 @default.
- W4313482854 cites W2728065598 @default.
- W4313482854 cites W2759516603 @default.
- W4313482854 cites W2784585580 @default.
- W4313482854 cites W2792793299 @default.
- W4313482854 cites W2806429275 @default.
- W4313482854 cites W2883998504 @default.
- W4313482854 cites W2906339590 @default.
- W4313482854 cites W2944598032 @default.
- W4313482854 cites W2971635939 @default.
- W4313482854 cites W2978559619 @default.
- W4313482854 cites W2980619113 @default.
- W4313482854 cites W2985217641 @default.
- W4313482854 cites W3017048037 @default.
- W4313482854 cites W3030982632 @default.
- W4313482854 cites W3079330638 @default.
- W4313482854 cites W3082916716 @default.
- W4313482854 cites W3093022306 @default.
- W4313482854 cites W3093197805 @default.
- W4313482854 cites W3109694774 @default.
- W4313482854 cites W3112412250 @default.
- W4313482854 cites W3113260540 @default.
- W4313482854 cites W3157217079 @default.
- W4313482854 cites W3165095816 @default.
- W4313482854 cites W3168924500 @default.
- W4313482854 cites W3199356946 @default.
- W4313482854 cites W4200432913 @default.
- W4313482854 cites W4212867045 @default.
- W4313482854 cites W4234845642 @default.
- W4313482854 cites W4235617745 @default.
- W4313482854 cites W4242700829 @default.
- W4313482854 cites W4246525590 @default.
- W4313482854 cites W4322701733 @default.
- W4313482854 doi "https://doi.org/10.1001/jamadermatol.2022.5607" @default.
- W4313482854 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36598763" @default.
- W4313482854 hasPublicationYear "2023" @default.
- W4313482854 type Work @default.
- W4313482854 citedByCount "3" @default.
- W4313482854 countsByYear W43134828542023 @default.
- W4313482854 crossrefType "journal-article" @default.
- W4313482854 hasAuthorship W4313482854A5010784869 @default.
- W4313482854 hasAuthorship W4313482854A5015031582 @default.
- W4313482854 hasAuthorship W4313482854A5042242906 @default.
- W4313482854 hasAuthorship W4313482854A5046355810 @default.
- W4313482854 hasAuthorship W4313482854A5049250271 @default.
- W4313482854 hasAuthorship W4313482854A5062709888 @default.
- W4313482854 hasAuthorship W4313482854A5066408267 @default.
- W4313482854 hasAuthorship W4313482854A5083560920 @default.
- W4313482854 hasConcept C116567970 @default.
- W4313482854 hasConcept C126322002 @default.
- W4313482854 hasConcept C151956035 @default.
- W4313482854 hasConcept C156957248 @default.
- W4313482854 hasConcept C201903717 @default.
- W4313482854 hasConcept C2908647359 @default.
- W4313482854 hasConcept C60644358 @default.
- W4313482854 hasConcept C71924100 @default.